Shares of Rock Creek Pharmaceuticals Inc (NASDAQ: RCPI), engaged in the business of selling nutraceutical dietary supplements and related cosmetic products, recorded over 11.0% gain during each of the past two consecutive trading sessions with significant number of shares exchanging hands. RCPI was the top performer in the U.S. healthcare sector after gaining 17.5% and closed at $0.20 Thursday, while recording significant trading volumes of 3.5 million shares. During the past 5-trading sessions, RCPI gained 25.3% with daily average trading volumes of 1.4 million shares, while the stock fell by 7.8% during the past one month with daily average trading volumes of 1.1 million shares.
Company Description:
Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI) develops and commercializes therapeutic drugs. The company sells supplements to treat inflammatory conditions, clinical immunology, neurological disease and behavioral health.
1-Year Stock Chart:
Source: Bloomberg
